New data support performing cataract surgery at more physiologic IOP in patients with ocular comorbidities—diabetic retinopathy and glaucoma 1

新数据支持在患有糖尿病视网膜病变和青光眼1的眼部合并症患者中以更高的生理IOP进行白内障手术

Scientific studies reinforce low visual disturbances and consistent, excellent outcomes with Alcon PCIOLs 2-5

科学研究使用Alcon PCIOLs 2-5加强了低视力障碍和一致的优异结果

Interactive, artistic partnership with Eyes of the World supports medical missions, underscores Alcon commitment to social impact, sustainability

与世界之眼的互动艺术合作支持医疗任务，强调了爱尔康对社会影响和可持续性的承诺

FORT WORTH, September 4, 2024 – Alcon (SIX/NYSE: ALC),

沃思堡，2024年9月4日–爱尔康（SIX/纽约证券交易所：ALC），

the global leader in eye care dedicated to helping people see brilliantly,

，

will present compelling scientific data at the 42nd Congress of the European

将在第42届欧洲大会上提供令人信服的科学数据

Society of Cataract and Refractive Surgeons (ESCRS) in Barcelona, Spain, from

西班牙巴塞罗那白内障和屈光外科医生协会（ESCRS）

September 6-10. Numerous abstracts will highlight Alcon’s leading

9月6日至10日。大量摘要将突出Alcon的领先地位

surgical ophthalmic products and equipment, designed for optimized patient

眼科手术产品和设备，专为优化患者而设计

outcomes and operational efficiencies. Educational opportunities and symposia

成果和运营效率。教育机会和研讨会

will highlight the Alcon Vision Suite portfolio, including advanced diagnostic

将重点介绍Alcon Vision Suite产品组合，包括高级诊断

technologies, intraocular lenses (IOLs) as well as the Wavelight®

技术，人工晶状体（IOL）以及Wavelight®

refractive platform. The complete schedule of Alcon ESCRS events is available

折射平台。可以获得爱尔康ESCRS活动的完整时间表

at

在

MyAlcon.com.

MyAlcon.com。

“We are thrilled to continue championing innovation for our surgeons and

“我们很高兴能继续为我们的外科医生和

patients with our robust collection of scientific data and education

我们收集了大量科学数据和教育的患者

activities at this year’s ESCRS,” said Sunil Vasanth,

Sunil Vasanth说，

Alcon’s Vice President Surgical Franchise, Europe. “The tangible

爱尔康欧洲外科副总裁。“有形的

impact that our ground-breaking research and development efforts are having on

我们开创性的研究和开发工作对

our customers—and ophthalmology as a whole—is clearer than ever,

我们的客户和整个眼科比以往任何时候都更加清晰，

and we’re excited to demonstrate that in Barcelona.”

我们很高兴能在巴塞罗那证明这一点。”

Results support operating at a more physiologic intraocular pressure (IOP)

结果支持在更生理的眼内压（IOP）下操作

in cataract

surgery. Steel et al. finds that phacoemulsification with

手术。Steel等人发现超声乳化术

CENTURION® Vision System with Active Sentry® at higher (60 mmHg) and

CENTURION®视觉系统，具有较高（60 mmHg）和

lower near physiologic (30 mmHg) IOP provides similar surgical efficiency and

较低的近生理（30 mmHg）眼压可提供相似的手术效率和

anatomical outcomes in patients with ocular comorbidities. Near physiologic

眼部合并症患者的解剖学结果。

IOP group showed less reduction in the foveal avascular zone (FAZ).1

眼压组中央凹无血管区（FAZ）减少较少

Other presentations adding to the growing body of evidence around the benefits

其他演示文稿增加了围绕好处的越来越多的证据

of operating at a more physiological IOP include:

在更生理的眼压下操作包括：

To Explore The Impact Of Different Intraocular Pressure Settings On The

探讨不同眼压设置对

Safety And Prognosis In Phacoemulsification, presented by Dr. Shouyan

Shouyan博士介绍的超声乳化术的安全性和预后

Wanga.6

王。6

In addition to these studies, Alcon’s Medical Affairs team will host a

除了这些研究之外，爱尔康的医疗事务团队还将主持

medical symposium

医学研讨会

“Why it matters to perform cataract surgery at a near physiologic IOP?” on Sunday, September 8 at 9:30 CEST, moderated by Prof. Dr. Gäbor

“为什么在接近生理眼压的情况下进行白内障手术很重要？”CEST 9月8日周日9:30，由Gäbor教授主持

Scharioth. For more information on Medical Affairs activities at ESCRS, please

沙里奥斯。有关ESCRS医疗事务活动的更多信息，请

visit

参观

Medical Affairs | MyAlcon | International.

医疗事务|迈尔康|国际。

Data from multiple

来自多个

studies reinforce low

研究加强了低

instances of visual

可视化实例

disturbances and high

干扰和高

spectacle independence for

眼镜独立性

PanOptix®. In a study

PanOptix®。在一项研究中

by Kohnen et al. on Clareon® PanOptix, visual performance of the PanOptix

Kohnen等人在Clareon®PanOptix上，PanOptix的视觉性能

IOL showed good visual acuity at all distances, high patient satisfaction and

人工晶状体在所有距离均显示出良好的视力，患者满意度高

spectacle independence, and good contrast sensitivity with no glistenings 12

眼镜独立性，对比敏感度好，无闪烁12

months postoperatively. 2 Data from Modi demonstrates lower instances of visual

术后数月。2来自Modi的数据显示了较低的视觉实例

disturbances at 6 months post-op in AcrySof® IQ PanOptix IOLs, when

AcrySof®IQ PanOptix人工晶状体术后6个月出现紊乱

compared to TECNIS Synergy*.3 A study from Zhu also finds the risks of

与TECNIS Synergy*3相比。朱的一项研究还发现

“severe” and “very bothersome” visual disturbances

“严重”和“非常烦人”的视觉障碍

(halos, glares and starbursts) to be low in patients with bilateral

双侧患者（光晕、眩光和星暴）较低

implantation of AcrySof IQ PanOptix IOLs.4 Attendees can also view additional

PanOptix data, most notably:

PanOptix数据，最值得注意的是：

Evaluation of reading performance after diffractive trifocal IOL

衍射三焦点人工晶状体后的阅读性能评价

implantation in refractive lens exchange using an electronic reading desk,

使用电子阅览台植入屈光镜片交换，

presented by Dr. Ramin Khoramnia.5

由Ramin Khoramnia博士介绍。5

Additional data support consistent outcomes with Alcon Vivity® IOLs, including a study from Urcola,

其他数据支持与Alcon Vivity®IOL一致的结果，包括Urcola的一项研究，

Lauzirika et al. showing Vivity’s continued success in delivering

Lauzirika等人展示了Vivity在交付方面的持续成功

excellent visual outcomes at all distances, even in patients with mild and

即使在轻度和重度

stable primary open-angle glaucoma.7 Additional data from Sararols et al.

稳定的原发性开角型青光眼。7 Sararols等人的其他数据。

demonstrates Vivity excellent outcomes with patients undergoing

在接受治疗的患者中表现出良好的活力

phacoemulsification in one eye and phacovitrectomy for epiretinal membrane in

一只眼白内障超声乳化术和视网膜前膜超声乳化玻璃体切除术

the fellow eye.8

Alcon to host robust educational program at ESCRS and commercially launch

爱尔康将在ESCRS上主办强大的教育计划并进行商业启动

Fidelis™ VR

Fidelis™VR

simulator. This year, Alcon will support the ESCRS Education

模拟器。今年，爱尔康将支持ESCRS教育

Lab, where nearly 150 surgeons will have the opportunity to experience the

实验室，近150名外科医生将有机会体验

Fidelis Virtual Reality Surgical Simulator for an immersive, haptic simulation

Fidelis虚拟现实手术模拟器，用于沉浸式触觉模拟

that aims to improve training outcomes and bolster surgical confidence.

这旨在改善训练效果并增强手术信心。

Fidelis software is now available commercially worldwide.

。

Three additional Alcon symposia and one near-live surgery session will feature

另外三场爱尔康研讨会和一场近现场手术会议将举行

Alcon products and services, including:

爱尔康产品和服务，包括：

“Breaking Barriers on Presbyopia Correcting Surgery” on Sunday, September 8 at 13:00 CEST, moderated by Prof. Ike

9月8日星期日13:00 CEST“打破老视矫正手术的障碍”，由Ike教授主持

Ahmed.

。

“Wavelight Refractive

“波光折射

Platform: A paradigm

平台：一种范式

shift in personalized

precision,” on Saturday, September 7 at 16:00 CEST,

“精确”，9月7日星期六，CEST 16:00，

moderated by Mr. Arthur Cummings.

由Arthur Cummings先生主持。

“Alcon Eye to

“爱尔康着眼于

Eye –

眼睛–

Innovations which

创新

bring you confidence

给你带来自信

to do better,” on

Saturday, September 7 at 13:00 CEST, moderated by Prof. Antoine Brezin.

9月7日星期六13:00 CEST，由Antoine Brezin教授主持。

A unique opportunity to watch José F. Alfonso, MD, conduct a

观看医学博士何塞·阿方索（JoséF.Alfonso）进行

near-live cataract

近活白内障

surgery session on Saturday, September 7

9月7日星期六的手术课

at 14:00 CEST, which will include products from the Alcon Vision Suite and

CEST时间14:00，其中将包括Alcon Vision Suite和

Alcon IOLs.

以及IOL。

Additional educational opportunities and experiences for surgeons will be

外科医生的额外教育机会和经验将是

available at the Alcon booth #7.A00, including hands-on sessions with our

Alcon展位#7.A00提供，包括与我们的

newly acquired Direct Selective Laser Trabeculoplasty (DSLT) device. For

新获得的直接选择性激光小梁成形术（DSLT）装置。对于

details on all Alcon ESCRS activities,

所有爱尔康ESCRS活动的详细信息，

click here.

单击此处。

Social Impact and

社会影响和

Sustainability (SIS) will

可持续发展（SIS）将

be at the

在

forefront of the

最前沿的

ESCRS Congress for

ESCRS大会

Alcon with an

Alcon与

interactive art

互动艺术

display. Alcon will proudly present the “Gaze

显示器。爱尔康将自豪地展示“凝视”

Machine – Your Gaze,

机器——你的凝视，

Their Vision,” an interactive digital

他们的愿景，“交互式数字

art exhibition designed by contemporary artist, Solimán López.

当代艺术家索利曼·洛佩斯设计的艺术展。

For each participant gaze captured at booth 6.F77, Alcon will fund an

对于在6.F77展位拍摄的每位参与者的凝视，爱尔康将资助

operation during an upcoming medical mission organized by

在即将到来的医疗任务中的行动

Eyes of the World, a non-profit organization that works to eradicate

世界之眼，一个致力于根除

preventable blindness in some of the most vulnerable areas of the world. This

世界上一些最脆弱地区的可预防失明。这个

digital artwork will be exhibited in various art spaces following ESCRS to

数字艺术品将在ESCRS之后的各个艺术空间展出

educate communities about the importance of eye health and the detection,

，

diagnosis, treatment and prevention of ocular diseases that can lead to

眼部疾病的诊断、治疗和预防

blindness.

失明。

Alcon is also a three-year partner

爱尔康也是一名三年期合伙人

for the ESCRS’

对于ESCRS

Building Our Sustainable,

，

Inclusive Society (BOSS) program, which is

包容性社会（BOSS）计划

dedicated to creating an environment where everyone feels that they are part

致力于创造一个每个人都觉得自己是其中一部分的环境

of an inclusive and open culture. Alcon leaders will play active roles in this

。爱尔康领导将在这方面发挥积极作用

year’s dedicated mentoring sessions and symposia. Alcon continues to

一年专门的指导会议和专题讨论会。爱尔康继续

join forces with the ESCRS in

与ESCRS联合

standing for environmental sustainability by providing water

通过提供水代表环境可持续性

stations throughout the congress venue to help reduce plastic waste. More

整个会议场地都设有车站，以帮助减少塑料废物。更多

information surrounding Alcon’s ongoing SIS initiatives and progress can

有关Alcon正在进行的SIS计划和进展的信息可以

be found in the

在中找到

2023 Social Impact and Sustainability Report.

2023年社会影响和可持续发展报告。

Alcon medical device(s) comply

爱尔康医疗器械符合

with the current legislation for

根据目前的立法

the medical devices. Please

医疗设备。求你了

refer to

参考

relevant products directions for use or operator’s manuals for

相关产品使用说明或操作手册

complete lists of indications,

完整的适应症列表，

contraindications and warnings.

禁忌症和警告。

Products mentioned may not be

提到的产品可能不是

approved in all markets; please

在所有市场获得批准；拜托

reach out to your Alcon

Representative for questions about

问题代表

availability in your local

在您当地的可用性

market.

市场。

This content is intended for

此内容旨在

Healthcare Professionals (HCPs) only.

仅限医疗保健专业人员（HCP）。

Please note that product-related

请注意，产品相关

promotion of Medical Devices to

医疗器械的推广

non-HCPs may be subject to

非HCP可能会受到

restrictions based on local

基于本地的限制

rules and regulations.

规章制度。

About Alcon

关于爱尔康

Alcon helps people see brilliantly. As the global leader in eye care with a

爱尔康帮助人们看到光明。作为全球眼科护理领导者

heritage spanning over 75 years, we offer the broadest portfolio of products

to enhance sight and improve people’s lives. Our Surgical and Vision

提高视力，改善人们的生活。我们的手术和视力

Care products touch the lives of more than 260 million people in over 140

护理产品触及140多个国家2.6亿多人的生命

countries each year living with conditions like cataracts, glaucoma, retinal

每年患有白内障、青光眼、视网膜疾病的国家

diseases and refractive errors. Our more than 25,000 associates are enhancing

疾病和屈光不正。我们的25000多名员工正在提高

the quality of life through innovative products, partnerships with Eye Care

通过创新产品、与眼部护理合作提高生活质量

Professionals and programs that advance access to quality eye care. Learn more

专业人士和计划，提高获得优质眼部护理的机会。了解更多信息

at www.alcon.com.

at www.alcon.com.

Trademarks are property of their respective owners.

商标是其各自所有者的财产。

References

参考文献

Steel, David, et al. The Effect Of Intraocular Pressure During

Steel，David等人。眼内压的影响

Phacoemulsification In Patients With Diabetic Retinopathy And Glaucoma; A

糖尿病视网膜病变和青光眼患者的超声乳化术；A

Randomised Controlled Feasibility Trial. ESCRS, Barcelona. September 2024.

。ESCRS，巴塞罗那。2024年9月。

Kohnen. Implantation Of A Presbyopia Correcting IOL With New Hydrophobic

科宁。新型疏水性人工晶状体植入术矫正老视

Material: 12 Months Results. ESCRS, Barcelona. September 2024.

材料：12个月的结果。ESCRS，巴塞罗那。2024年9月。

Modi S., Lehmann R. Comparison of Visual Function Between Two

Modi S.，Lehmann R.两者视觉功能的比较

Presbyopia-Correcting Intraocular Lenses: A Randomized Bilateral Study.

老视矫正人工晶状体：一项随机双侧研究。

Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.

论文发表于：ASCRS年会；2024年4月5日至8日；波士顿。

Zhu D., Zhang J. Patient-Reported Outcomes of Visual Disturbances with a

Zhu D.，Zhang J.患者报告了视力障碍的结果

Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS

三焦点人工晶状体：荟萃分析。论文发表于：ASCRS

Annual Meeting; April 5-8, 2024; Boston.

年度会议；2024年4月5日至8日；波士顿。

Khoramnia R, MD, Hassel O. Evaluation Of Reading Performance After

Khoramnia R，MD，Hassel O.阅读后的阅读表现评估

Diffractive Trifocal IOL Implantation In Refractive Lens Exchange Using An

衍射三焦点人工晶状体植入术在屈光性晶状体交换中的应用

Electronic Reading Desk. ESCRS, Barcelona. September 2024.

电子阅览台。ESCRS，巴塞罗那。2024年9月。

Wang, Shouyan. Comparison of clinical outcomes of cataract surgery using

王寿燕。白内障手术的临床结果比较

low IOP versus traditional intraoperative IOP setting. ESCRS, Barcelona.

低眼压与传统术中眼压设置相比。ESCRS，巴塞罗那。

September 2024.

2024年9月。

Urcola J A., Lauzirika, G., et al. Evaluation Of Visual Outcomes After

Implantation Of An Extended Depth-Of-Focus Intraocular Lens In Patients

扩大焦深人工晶状体植入术

With Mild Glaucoma. ESCRS, Barcelona. September 2024.

患有轻度青光眼。ESCRS，巴塞罗那。2024年9月。

Sararols, Laura. A Prospective Study Of The Bilateral Implantation Of An

。双侧An植入的前瞻性研究

Extended Depth Of Focus Intraocular Lens In Patients Undergoing

扩大焦深人工晶状体植入术

Phacoemulsification In One Eye And Phacovitrectomy For Epiretinal Membrane

一只眼白内障超声乳化术及视网膜前膜超声乳化玻璃体切除术

In The Fellow Eye. ESCRS, Barcelona. September 2024.

在对方眼中。ESCRS，巴塞罗那。2024年9月。

Investor Relations

投资者关系

Allen Trang

艾伦·佩奇

+ 41 589 112 110 (Geneva)

+41 589 112 110（日内瓦）

+ 1 817 615 2789 (Fort Worth)

+1817 615 2789（沃思堡）

[email protected]

[受电子邮件保护]

Media Relations

媒体关系

Cara Jones-Faye

亲爱的Jones Faye

+ 41 79 93 3811 (Geneva)

+41 79 93 3811（日内瓦）

[email protected]

[受电子邮件保护]